Published in Metabolism on March 01, 1985
AIMilano apoprotein identification of the complete kindred and evidence of a dominant genetic transmission. Am J Hum Genet (1985) 0.95
Genetic basis of lipoprotein disorders. J Clin Invest (1989) 0.93
Conformation of dimeric apolipoprotein A-I milano on recombinant lipoprotein particles. Biochemistry (2010) 0.86
A single infusion of MDCO-216 (ApoA-1 Milano/POPC) increases ABCA1-mediated cholesterol efflux and pre-beta 1 HDL in healthy volunteers and patients with stable coronary artery disease. Eur Heart J Cardiovasc Pharmacother (2015) 0.78
Association of apolipoprotein E E4 with vascular dementia. JAMA (1994) 2.48
A-IMilano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family. J Clin Invest (1980) 2.27
Pravastatin reduces carotid intima-media thickness progression in an asymptomatic hypercholesterolemic mediterranean population: the Carotid Atherosclerosis Italian Ultrasound Study. Am J Med (1996) 1.99
Disposition of metformin (N,N-dimethylbiguanide) in man. Clin Pharmacol Ther (1978) 1.50
Cardiovascular status of carriers of the apolipoprotein A-I(Milano) mutant: the Limone sul Garda study. Circulation (2001) 1.31
Gene dose of the epsilon 4 allele of apolipoprotein E and disease progression in sporadic late-onset Alzheimer's disease. Ann Neurol (1995) 1.29
Secretory processing of amyloid precursor protein is inhibited by increase in cellular cholesterol content. Biochem J (1997) 1.27
Apolipoprotein A-IMilano. Detection of normal A-I in affected subjects and evidence for a cysteine for arginine substitution in the variant A-I. J Biol Chem (1983) 1.23
Cholesterol efflux from Fu5AH hepatoma cells induced by plasma of subjects with or without coronary artery disease and non-insulin-dependent diabetes: importance of LpA-I:A-II particles and phospholipid transfer protein. Atherosclerosis (1996) 1.20
Evaluation of selected hypolipidemic agents for the induction of peroxisomal enzymes and peroxisome proliferation in the rat liver. Hum Toxicol (1983) 1.20
Oncoplastic techniques in the conservative surgical treatment of breast cancer. Breast Cancer (2000) 1.19
Carotid artery intima-media thickness measured by ultrasonography in normal clinical practice correlates well with atherosclerosis risk factors. Stroke (2000) 1.14
Pharmacokinetics of ribavirin and urinary excretion of the major metabolite 1,2,4-triazole-3-carboxamide in normal volunteers. Int J Clin Pharmacol Ther Toxicol (1989) 1.13
Very low density lipoproteins in normal and cholesterol-fed rabbits: lipid and protein composition and metabolism. Part 1. Chemical composition of very low density lipoproteins in rabbits. Atherosclerosis (1988) 1.11
Triglycerides are major determinants of cholesterol esterification/transfer and HDL remodeling in human plasma. Arterioscler Thromb Vasc Biol (1995) 1.10
Parametric analysis of the strength in the ''Toronto'' osseous-prosthesis system. Minerva Stomatol (2009) 1.08
Effects of fibrates on serum lipids and atherosclerosis. Pharmacol Ther (1988) 1.06
Diffusion-weighted imaging in breast cancer: relationship between apparent diffusion coefficient and tumour aggressiveness. Clin Radiol (2010) 1.06
A-Imilano apoprotein. Isolation and characterization of a cysteine-containing variant of the A-I apoprotein from human high density lipoproteins. J Clin Invest (1980) 1.05
Metabolic responses to acute and chronic L-dopa administration in patients with parkinsonism. N Engl J Med (1972) 1.04
Omacor in familial combined hyperlipidemia: effects on lipids and low density lipoprotein subclasses. Atherosclerosis (2000) 1.04
Soybean-protein diet in the treatment of type-II hyperlipoproteinaemia. Lancet (1977) 0.99
Increased cholesterol efflux potential of sera from ApoA-IMilano carriers and transgenic mice. Arterioscler Thromb Vasc Biol (1999) 0.98
Cardiac, skeletal, and ocular abnormalities in patients with Marfan's syndrome and in their relatives. Comparison with the cardiac abnormalities in patients with kyphoscoliosis. Br Heart J (1984) 0.98
Apolipoprotein E epsilon 4 allele in Alzheimer's disease and vascular dementia. Dementia (1994) 0.96
Plasma lipid lowering activity of acipimox in patients with type II and type IV hyperlipoproteinemia. Results of a multicenter trial. Atherosclerosis (1988) 0.96
Activation of lecithin cholesterol acyltransferase by a disulfide-linked apolipoprotein A-I dimer. Biochem Biophys Res Commun (1997) 0.95
Genetic variants of group A apolipoproteins. Rapid methods for screening and characterization without ultracentrifugation. J Biol Chem (1982) 0.95
Plasma lipoprotein(a) is an independent factor associated with carotid wall thickening in severely but not moderately hypercholesterolemic patients. Stroke (1996) 0.95
AIMilano apoprotein identification of the complete kindred and evidence of a dominant genetic transmission. Am J Hum Genet (1985) 0.95
Reduced triglyceridemia and increased high density lipoprotein cholesterol levels after treatment with acipimox, a new inhibitor of lipolysis. Atherosclerosis (1981) 0.94
Inhibition of VCAM-1 expression in endothelial cells by reconstituted high density lipoproteins. Biochem Biophys Res Commun (1997) 0.94
High-performance liquid chromatographic determination of ribavirin in serum and urine and of its urinary metabolite 1,2,4-triazole-3-carboxamide. J Chromatogr (1987) 0.93
Reconstituted high-density lipoproteins with a disulfide-linked apolipoprotein A-I dimer: evidence for restricted particle size heterogeneity. Biochemistry (1997) 0.93
Inhibition of lipolysis by nicotinic acid and by acipimox. Clin Pharmacol Ther (1980) 0.93
Changes of n-3 and n-6 fatty acids in plasma and circulating cells of normal subjects, after prolonged administration of 20:5 (EPA) and 22:6 (DHA) ethyl esters and prolonged washout. Biochim Biophys Acta (1993) 0.92
Limited proteolysis of a disulfide-linked apoA-I dimer in reconstituted HDL. J Lipid Res (2001) 0.92
Increased plasma and aortic triglycerides in rabbits after acute administration of 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Appl Pharmacol (1984) 0.91
Apolipoprotein AIMilano. Accelerated binding and dissociation from lipids of a human apolipoprotein variant. J Biol Chem (1985) 0.91
Genetic Variability of Grapevine Pinot gris virus and Its Association with Grapevine Leaf Mottling and Deformation. Phytopathology (2015) 0.91
Solid breast mass characterisation: use of the sonographic BI-RADS classification. Radiol Med (2007) 0.91
Soy protein peptides regulate cholesterol homeostasis in Hep G2 cells. J Nutr (2000) 0.90
Therapy with HMG CoA reductase inhibitors: characteristics of the long-term permanence of hypocholesterolemic activity. Atherosclerosis (1995) 0.90
A point mutation in ABC1 gene in a patient with severe premature coronary heart disease and mild clinical phenotype of Tangier disease. Atherosclerosis (2001) 0.88
Characterization of A-I-containing lipoproteins in subjects with A-I Milano variant. Biochim Biophys Acta (1988) 0.88
High uptake of colonoscopy in first-degree relatives of patients with colorectal cancer in a healthcare region: a population-based, prospective study. Endoscopy (2010) 0.88
Relationship of the phenotypic expression of the A-IMilano apoprotein with plasma lipid and lipoprotein patterns. Atherosclerosis (1985) 0.87
Intima-media thickness after pravastatin stabilizes also in patients with moderate to no reduction in LDL-cholesterol levels: the carotid atherosclerosis Italian ultrasound study. Atherosclerosis (2000) 0.87
19p deletion in recurring leiomyosarcoma lesions from the same patient. Cancer Genet Cytogenet (2000) 0.87
Direct effects of statins on the vascular wall. J Cardiovasc Pharmacol (1998) 0.86
Reverse cholesterol transport: physiology and pharmacology. Atherosclerosis (1991) 0.86
Effects of dietary proteins on the regulation of liver lipoprotein receptors in rats. J Nutr (1984) 0.86
Metabolism of apolipoproteins AI and AII in subjects carrying similar apoAI mutations, apoAI Milano and apoAI Paris. Atherosclerosis (2000) 0.85
Role of isoflavones in the cholesterol reduction by soy proteins in the clinic. Am J Clin Nutr (1997) 0.85
Relation between the HDL apoproteins and AI isoproteins in subjects with the AIMilano abnormality. Metabolism (1981) 0.85
Hepatic peroxisome proliferation: induction by BR-931, a hypolipidemic analog of WY-14,643. Arch Int Pharmacodyn Ther (1978) 0.85
Common carotid intima-media thickness measurement. A method to improve accuracy and precision. Stroke (1994) 0.85
7S globulin from soybean is metabolized in human cell cultures by a specific uptake and degradation system. J Nutr (1996) 0.85
Low density lipoprotein receptor activity is modulated by soybean globulins in cell culture. J Nutr (1992) 0.85
Human apolipoproteins A-I and A-II in cell cholesterol efflux: studies with transgenic mice. Arterioscler Thromb Vasc Biol (1998) 0.84
Recombinant apolipoprotein A-IMilano dimer inhibits carotid intimal thickening induced by perivascular manipulation in rabbits. Circ Res (1995) 0.84
Controlled evaluation of fat intake in the Mediterranean diet: comparative activities of olive oil and corn oil on plasma lipids and platelets in high-risk patients. Am J Clin Nutr (1986) 0.84
Statins enhance arachidonic acid synthesis in hypercholesterolemic patients. Nutr Metab Cardiovasc Dis (2001) 0.84
Development of a lipid-rich, soft plaque in rabbits, monitored by histology and intravascular ultrasound. Atherosclerosis (2001) 0.84
High density lipoprotein particle size restriction in apolipoprotein A-I(Milano) transgenic mice. J Lipid Res (1997) 0.83
Inhibition of antipyrine metabolism by low-dose contraceptives with gestodene and desogestrel. Clin Pharmacol Ther (1991) 0.83
Very low density lipoproteins in normal and cholesterol-fed rabbits: lipid and protein composition and metabolism. Part 2. Metabolism of very low density lipoproteins in rabbits. Atherosclerosis (1988) 0.83
Apolipoprotein AIMilano. Partial lecithin:cholesterol acyltransferase deficiency due to low levels of a functional enzyme. Biochim Biophys Acta (1990) 0.83
Elevated triglycerides and low HDL cholesterol in transgenic mice expressing human apolipoprotein A-I(Milano). Atherosclerosis (1998) 0.83
Inhibitor of proliferation of arterial smooth-muscle cells by fluvastatin. Lancet (1996) 0.83
Antioxidant system and serum trace elements in alpha-thalassaemia and Hb Lepore trait. Eur J Haematol (1987) 0.83
Effects of smoking regular or light cigarettes on brachial artery flow-mediated dilation. Atherosclerosis (2013) 0.83